To conclude, IFN-γ levels increased as disease progressed and discriminated UDC responders and non-responders independently of cirrhosis, whereas IFN-λ3 may have a role in advanced PBC that is distinct to IFN-λ2. The gene discussed is IFNL3; the disease is primary biliary cholangitis.